Inbound and Outbound Late-Stage Biomedical Research Technology

As China's economy transitions from one of a production economy to one focusing on more advanced technology, transactions within the biomedical industry will continue. However, despite purchasing power, the development of a great deal of the technology acquired from Western countries by Chinese investors with the intent of marketing the technology in China has not gone as well as Western firms had projected.


Our team works with Chinese investors who have the ability and integrity to properly bring to market the technology they acquire. We work with both sides to finalize a mutually beneficial relationship.

China's Volume of Deals from Overseas Markets in the Health Sector (USD)